Introduction. Carbapenem-resistant Pseudomonas aeruginosa is responsible for increased patient mortality.
Gap Statement. Five and 30 day in-hospital all-cause mortality in patients with P. aeruginosa infections were assessed, followed by evaluations concerning potential correlations between the type III secretion system (TTSS) genotype and the production of metallo-β-lactamase (MBL).
Methodology. This assessment comprised a retrospective cohort study including consecutive patients with carbapenem-resistant infections hospitalized in Brazil from January 2009 to June 2019. PCR analyses were performed to determine the presence of TTSS-encoding genes and MBL genes.
Results. The 30-day and 5-day mortality rates for 262 patients were 36.6 and 17.9 %, respectively. The unadjusted survival probabilities for up to 5 days were 70.55 % for patients presenting exoU-positive isolates and 86 % for those presenting exo-negative isolates. The use of urinary catheters, as well as the presence of comorbidity conditions, secondary bacteremia related to the respiratory tract, were independently associated with death at 5 and 30 days. The exoS gene was detected in 64.8 % of the isolates, the presence of the exoT and exoY genes varied and exoU genes occurred in 19.3 % of the isolates. The exoU genotype was significantly more frequent among multiresistant strains. MBL genes were not detected in 92 % of the isolates.
Conclusions. Inappropriate therapy is a crucial factor regarding the worse prognosis among patients with infections caused by multiresistant P. aeruginosa, especially those who died within 5 days of diagnosis, regardless of the genotype associated with TTSS virulence.
MonteroMM, López MontesinosI, KnobelH, MolasE, SorlíL et al. Risk factors for mortality among patients with Pseudomonas aeruginosa bloodstream infections: what is the influence of XDR phenotype on outcomes?. J Clin Med2020; 9:514 [View Article][PubMed]
Garcia-VidalC, Cardozo-EspinolaC, Puerta-AlcaldeP, MarcoF, TellezA et al. Risk factors for mortality in patients with acute leukemia and bloodstream infections in the era of multiresistance. PLoS One2018; 13:e0199531 [View Article][PubMed]
SaderHS, CastanheiraM, DuncanLR, FlammRK. Antimicrobial susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa isolates from United States medical centers stratified by infection type: results from the International Network for Optimal Resistance Monitoring (INFORM) surveillance program, 2015–2016. Diagn Microbiol Infect Dis2018; 92:69–74 [View Article][PubMed]
ShahrbanouIPJ, JalalM, AsgharS, VahidP, AbbasBB et al. Occurrence of a multidrug resistant Pseudomonas aeruginosa strains in hospitalized patients in southwest of Iran: Characterization of resistance trends and virulence determinants. Jundishapur J Microbiol2018; 11:e57341
WalktyA, Lagace-WiensP, AdamH, BaxterM, KarlowskyJ et al. Antimicrobial susceptibility of 2906 Pseudomonas aeruginosa clinical isolates obtained from patients in Canadian hospitals over a period of 8 years: results of the Canadian Ward surveillance study (CANWARD), 2008–2015. Diagn Microbiol Infect Dis2017; 87:60–63 [View Article][PubMed]
Ponce de LeonA, MerchantS, RamanG, AvendanoE, ChanJ et al.Pseudomonas infections among hospitalized adults in Latin America: a systematic review and meta-analysis. BMC Infect Dis2020; 20:250 [View Article][PubMed]
BalkhairA, Al-MuharrmiZ, Al'AdawiB, Al BusaidiI, TaherHB et al. Prevalence and 30-day all-cause mortality of carbapenem-and colistin-resistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae: Description of a decade-long trend. Int J Infect Dis2019; 85:10–15 [View Article][PubMed]
JácomePRLA, AlvesLR, Jácome-JúniorAT, SilvaMJBD, LimaJLDC et al. Detection of blaSPM-1, blaKPC, blaTEM and blaCTX-M genes in isolates of Pseudomonas aeruginosa, Acinetobacter spp. and Klebsiella spp. from cancer patients with healthcare-associated infections. J Med Microbiol2016; 65:658–665 [View Article][PubMed]
SharifiH, PouladfarG, ShakibaieMR, PourabbasB, MardanehJ et al. Prevalence of β-lactamase genes, class 1 integrons, major virulence factors and clonal relationships of multidrug-resistant Pseudomonas aeruginosa isolated from hospitalized patients in southeast of Iran. Iran J Basic Med Sci2019; 22:806–812 [View Article][PubMed]
QuilesMG, CarlesseF, da SilvaMA, MingroneRC, FonsecaJM et al. High mortality outbreak of carbapenem-resistant Pseudomonas aeruginosa infection in a Brazilian pediatric oncology hospital. Braz J Infect Dis2017; 21:205–206 [View Article][PubMed]
MatosEC, MatosHJ, ConceiçãoML, RodriguesYC, CarneiroIC et al. Clinical and microbiological features of infections caused by Pseudomonas aeruginosa in patients hospitalized in intensive care units. Rev Soc Bras Med Trop2016; 49:305–311 [View Article][PubMed]
BabichT, NauclerP, ValikJK, GiskeCG, BenitoN et al. Ceftazidime, carbapenems, or piperacillin-tazobactam as single definitive therapy for Pseudomonas aeruginosa bloodstream infection: a multisite retrospective study. Clin Infect Dis2020; 70:2270–2280 [View Article][PubMed]
TakataI, YamagishiY, MikamoH. Association of the exoU genotype with a multidrug non-susceptible phenotype and mRNA expressions of resistance genes in Pseudomonas aeruginosa. J Infect Chemother2018; 24:45–52 [View Article][PubMed]
El-SolhAA, HattemerA, HauserAR, AlhajhusainA, VoraH. Clinical outcomes of type III Pseudomonas aeruginosa bacteremia. Crit Care Med2012; 40:1157–1163 [View Article][PubMed]
KhodayaryR, NikokarI, MobayenMR, AfrasiabiF, AraghianA et al. High incidence of type III secretion system associated virulence factors (exoenzymes) in Pseudomonas aeruginosa isolated from Iranian burn patients. BMC Res Notes2019; 12:28 [View Article]
FerreiraML, DantasRC, FariaALS, GonçalvesIR, Silveira de BritoC et al. Molecular epidemiological survey of the quinolone- and carbapenem-resistant genotype and its association with the type III secretion system in Pseudomonas aeruginosa. J Med Microbiol2015; 64:262–271 [View Article][PubMed]
DaikosGL, TsaousiS, TzouvelekisLS, AnyfantisI, PsichogiouM et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob Agents Chemother2014; 58:2322–2328 [View Article][PubMed]
MagiorakosAP, SrinivasanA, CareyRB, CarmeliY, FalagasME et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect2012; 18:268–281 [View Article][PubMed]
JabalameliF, MirsalehianA, KhoramianB, AligholiM, KhoramroozSS et al. Evaluation of biofilm production and characterization of genes encoding type III secretion system among Pseudomonas aeruginosa isolated from burn patients. Burns2012; 38:1192–1197 [View Article][PubMed]
KhodayaryR, NikokarI, MobayenMR, AfrasiabiF, AraghianA et al. High incidence of type III secretion system associated virulence factors (exoenzymes) in Pseudomonas aeruginosa isolated from Iranian burn patients. BMC Res Notes2019; 12:28 [View Article][PubMed]
SubediD, VijayAK, KohliGS, RiceSA, WillcoxM. Association between possession of ExoU and antibiotic resistance in Pseudomonas aeruginosa. PLoS One2018; 13:e0204936 [View Article][PubMed]
MorrowKA, OchoaCD, BalczonR, ZhouC, CauthenL et al.Pseudomonas aeruginosa exoenzymes U and Y induce a transmissible endothelial proteinopathy. Am J Physiol Lung Cell Mol Physiol2016; 310:L337–L353 [View Article]
Aditi, ShariffM, ChhabraSK, RahmanM-U. Similar virulence properties of infection and colonization associated Pseudomonas aeruginosa. J Med Microbiol2017; 66:1489–1498 [View Article][PubMed]
DiasVC, ResendeJA, BastosAN, De Andrade BastosLQ, De Andrade BastosVQ et al. Epidemiological, physiological and molecular characteristics of a Brazilian collection of carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Microb Drug Resist2017; 23:852–863 [View Article][PubMed]
AvivT, LazarovitchT, KatzD, ZaidensteinR, DadonM et al. The epidemiological impact and significance of carbapenem resistance in Pseudomonas aeruginosa bloodstream infections: a matched case-case-control analysis. Infect Control Hosp Epidemiol2018; 39:1262–1265 [View Article][PubMed]
BrittNS, RitchieDJ, KollefMH, BurnhamCA, DurkinMJ et al. Importance of site of infection and antibiotic selection in the treatment of carbapenem-resistant Pseudomonas aeruginosa sepsis. Antimicrob Agents Chemother2018; 62:pii: e02400-17. [View Article][PubMed]
DantasRC, FerreiraML, Gontijo-FilhoPP, RibasRM. Pseudomonas aeruginosa bacteraemia: independent risk factors for mortality and impact of resistance on outcome. J Med Microbiol2014; 63:1679–1687 [View Article][PubMed]
JooEJ, KangCI, HaYE, ParkSY, KangS-J et al. Impact of inappropriate empiric antimicrobial therapy on outcome in Pseudomonas aeruginosa bacteraemia: a stratified analysis according to sites of infection. Infection2011; 39:309–318 [View Article][PubMed]
PengY, BiJ, ShiJ, LiY, YeX, XiaofengX et al. Multidrug-resistant Pseudomonas aeruginosa infections pose growing threat to health care-associated infection control in the hospitals of Southern China: a case-control surveillance study. Am J Infect Control2014; 42:1308–1311 [View Article][PubMed]
CezárioRC, Duarte De MoraisL, FerreiraJC, Costa-PintoRM, da Costa DariniAL et al. Nosocomial outbreak by imipenem-resistant metallo-β-lactamase-producing Pseudomonas aeruginosa in an adult intensive care unit in a Brazilian teaching hospital. Enferm Infecc Microbiol Clin2009; 27:269–274 [View Article][PubMed]
HornaG, AmaroC, PalaciosA, GuerraH, RuizJ. High frequency of the exoU+/exoS+ genotype associated with multidrug-resistant “high-risk clones” of Pseudomonas aeruginosa clinical isolates from Peruvian hospitals. Sci Rep2019; 9:10874 [View Article][PubMed]